Get the Stockscreener App
5.25
7.58%
0.37
Pre-market:
4.92
-0.33
-6.29%
Endra Life Sciences Inc stock is traded at $5.25, with a volume of 45,661.
It is up +7.58% in the last 24 hours and down -2.42% over the past month.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
See More
Previous Close:
$4.88
Open:
$4.93
24h Volume:
45,661
Relative Volume:
0.17
Market Cap:
$3.95M
Revenue:
-
Net Income/Loss:
$-8.82M
P/E Ratio:
-0.00759
EPS:
-691.4213
Net Cash Flow:
$-8.08M
1W Performance:
+5.00%
1M Performance:
-2.42%
6M Performance:
-12.65%
1Y Performance:
-40.36%
1-Day Range:
$4.87
$5.37
1-Week Range:
$4.79
$5.43
52-Week Range:
$2.90
$11.96
Endra Life Sciences Inc Stock (NDRA) Company Profile
Name
Endra Life Sciences Inc
Sector
Industry
Phone
734-335-0468
Address
3600 GREEN COURT, ANN ARBOR, MI
Compare NDRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
5.25 | 7.31M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Endra Life Sciences Inc Stock (NDRA) Latest News
What the charts say about ENDRA Life Sciences Inc. todayJuly 2025 Intraday Action & Daily Chart Pattern Signals - newser.com
Can ENDRA Life Sciences Inc. recover in the next quarterEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Can ENDRA Life Sciences Inc. rally from current levels2025 Support & Resistance & Fast Gaining Stock Reports - newser.com
When is the best time to exit ENDRA Life Sciences Inc.Earnings Overview Report & Risk Controlled Daily Trade Plans - newser.com
ENDRA Life Sciences Inc. stock daily chart insightsDay Trade & Real-Time Price Movement Reports - newser.com
What dividend safety score for ENDRA Life Sciences Inc. stockPortfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Combining machine learning predictions for ENDRA Life Sciences Inc.Quarterly Investment Review & Weekly Watchlist of Top Performers - newser.com
What to expect from ENDRA Life Sciences Inc. in the next 30 days2025 Retail Activity & Target Return Focused Stock Picks - newser.com
ENDRA Life Sciences Signs Sales Agreement with Lucid - MSN
What is ENDRA Life Sciences Inc (NDRA) Price Targets? - fostersleader.com
Will ENDRA Life Sciences Inc. benefit from macro trends2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
Published on: 2025-10-31 03:28:18 - newser.com
NDRA launches $1.75M at-the-market offering with Lucid Capital - Stock Titan
Published on: 2025-10-30 06:15:44 - newser.com
NDRA launches $1.75M at-the-market program; 3% commission - Stock Titan
Endra Life Sciences Inc enters ATM agreement with Lucid for up to $1.75 millionSEC filing - MarketScreener
Candlestick signals on ENDRA Life Sciences Inc. stock today2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
Published on: 2025-10-29 06:17:20 - newser.com
[ARS] ENDRA Life Sciences Inc. SEC Filing - Stock Titan
Form DEF 14A ENDRA Life Sciences Inc. For: Dec 31 - StreetInsider
Published on: 2025-10-27 21:50:48 - newser.com
How ENDRA Life Sciences Inc. stock responds to policy changesMarket Risk Report & Stepwise Entry and Exit Trade Signals - Fundação Cultural do Pará
How ENDRA Life Sciences Inc. stock trades before earningsJuly 2025 Earnings & Safe Investment Capital Preservation Plans - fcp.pa.gov.br
How ENDRA Life Sciences Inc. stock benefits from strong dollarJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - fcp.pa.gov.br
Endra Life Sciences Inc Stock (NDRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):